|
|
||||||||
| ABSTRACT |
|
|
|---|
| INTRODUCTION |
|
|
|---|
We have recently accomplished identification of cercariae14 and of snails infected with S. haematobium15 by using primers designed from a repeated sequence, DraI, in a PCR assay. DraI was not found in S. mansoni or S. japonicum by dot hybridization.14 However, because the DraI repeat is present in DNA of other schistosomes belonging to the S. haematobium group,14 the identification of S. haematobiuminfected snails by a simple PCR assay has been limited, thus far, to areas where these other S. haematobiumrelated schistosome species are absent or very rare.15
PCR, unlike other methods previously used for identifying snails with prepatent infection, has enabled detection of snail infection from its very earliest stages.15 It thus identifies the entire population of infected snails, regardless of whether they eventually shed cercariae, representing in quantitative terms the direct outcome of human contamination of water bodies.15 This approach has been applied to large-scale monitoring of infection in field snails at transmission sites in Coast Province, Kenya.15 Because differential identification of snails infected with S. haematobium is important for further evaluation of integrated control approaches in other endemic regions, we have undertaken a search for DNA sequences from which primers can be designed for differential identification of S. haematobium by means of simple PCR techniques.
| MATERIALS AND METHODS |
|
|
|---|
Normal and infected snails. Bulinus nasutus field snails were collected during 2001 from transmission sites in the Msambweni area of Kwale District, Coast Province, Kenya. Details of the study area have been described elsewhere.16 B. nasutus collected from transmission sites in this area exhibited high rates of prepatent S. haematobium infection as determined by PCR, ranging from 29% to 50% and patent infection ranging between 0.14% and 3.4%. Schistosomes of ruminants in these sites were found to be rare.15
Uninfected B. nasutus used for these studies were laboratory bred, taken from first- to fourth-generation stocks derived from the above-mentioned field collected snails (C. Kariuki and others, unpublished data). Snails were preserved in ethanol until subjected to DNA extraction.
DNA extraction. DNA was prepared from adult schistosome worms of all species as previously described.14 Briefly, the worms were kept in lysis buffer containing (0.1 mol/L Ethylenediaminetetraacetate, pH 8.0, 0.1 mol/L Tris-HCl, pH 7.5, 0.2 mol/L NaCl, 1% SDS, 0.2% 2-mercaptoethanol, and 100 µg Proteinase K) at 65°C for 12 hours. This was followed by phenol and chloroform extraction.
DNA from snails was extracted by the hexadecytrimethlammonium bromide (CTAB) extraction method as previously described.15 Briefly, snail bodies were removed from their shell and incubated in 0.6 mL of lysis buffer (100 mmol/L Tris base, 20 mmol/L EDTA, 1.4 mol/L NaCl, 0.2% ß-mercaptoethanol, 2% CTAB) and Proteinase K. After incubation for 3 hours at 60°C, nucleic acids were extracted twice by chloroform and precipitated with ethanol.
Construction of genomic DNA libraries. Genomic libraries were prepared from DNA of all the schistosomes included in this study. Materials for recombinant DNA technology, including enzymes used for restriction, ligation, and dephosphorylation, were from MBI Fermentas (Vilnius, Lithuania). Genomic DNA was partially digested by Sau3A restriction endonuclease, followed by phenol/chloroform extraction and ethanol precipitation. Digested DNA was ligated into the BamHI site of the Bluescript plasmid (Stratagene, La Jolla, CA), by standard methods.17 For additional genomic libraries of S. haematobium, DNA was digested by AluI or RsaI, and digestion products ligated into the SmaI site of the Blusescript plasmid. Ligation products were transformed into Escherichia coli, strain XL1-Blue, and were plated for color selection of recombinants by standard methods.17
Selection of repetitive DNA clones. The selected white recombinant colonies were transferred onto nylon filters and probed with 32P-labeled total S. haematobium genomic DNA. Colony lysis, DNA denaturation, and fixation onto the nylon filter were carried out in a microwave oven as previously described.18 Clones initially selected were those that exhibited strong hybridization signals with the homologous total DNA probe, indicating the presence of repeated sequences. These were transferred to a grid on a nylon filter, and a second level of selection was applied by hybridization with the DraI repeat of S. haematobium, shared by all of the schistosome species studied in this paper.15 Colonies not hybridizing with the DraI probe underwent a third level of selection involving cross-hybridization with total DNA from the other species and selection of those giving hybridization signals with S. haematobium DNA only. A fourth level of selection of candidate clones followed sequence analysis, with selection of those that exhibited the following features: 1) they were not similar to the DraI repeat; 2) they were not similar to known sequences from the other schistosomes included in this study nor to schistosomal sequences present in GenBank; and 3) when aligned with other sequences of the same species, sequences thereof were found to be represented more than once in the same species, suggesting a relatively high copy number.
Dot-blot and Southern blot analysis. Comparative dot-blot hybridization was performed to estimate the abundance of the sequence amplified by applying PCR using the selected primers (see below). Various concentrations of S. haematobium genomic DNA (ranging from 0.01 to 10 ng) and DNA of the said amplification product, ranging between 0.1 and 10 pg, were dotted onto a nitrocellulose membrane using a dot-blot apparatus (BioRad, Hercules, CA). These underwent denaturation and neutralization by standard procedures17 and were finally hybridized with radiolabeled total DNA probe and with the cloned amplification product probe.
Radiolabeling with 32P of genomic DNA, repetitive DNA clones, or PCR products used as probes was done by the Random Primer DNA Labeling Kit (Biologic Industries Co., Beit Haemek, Israel). Analysis of the dot hybridization signals was performed using the public domain NIH Image program (developed at the Research Services Branch at the US National Institute of Mental Health and available on the Internet at http://rsb.info.nih.gov/nih-image/about.html).
Southern blot analysis was performed, according to standard protocols17 for determining the distribution of the amplified DNA sequence (assumed to represent the DNA segment stretching between the primer sequences used). S. haematobium genomic DNA (1 µg) was partially digested by RsaI or AluI restriction enzymes followed by Southern transfer to nitrocellulose filter and probing by the corresponding amplification product.
Filter hybridization. This was done according to standard procedures.17 The filters were incubated for 2 hours at 65°C in a prehybridization solution (6x sodium chloride, sodium citrate [SSC], 10x Denhardt solution, 0.1% SDS, and 100 µg/ mL denatured salmon sperm DNA). The radiolabeled probe was directly added to the filters in the prehybridization solution at 60°C for overnight. The filters were washed once in 2x SSC at room temperature for 30 minutes, followed by two washes with 2x SSC, 0.1% SDS at 60°C for 15 minutes each time. Filters were air-dried and exposed to x-ray film.
Primer design and PCR assay. Primers were designed by using the PRIME software version 9.0, of the Wisconsin Package (Genetic Computer Group [GCG], Madison, WI) based on the sequence information of the newly described repeated sequences of S. haematobium selected for these experiments.
The primer combination ultimately enabling specific amplification of S. haematobium DNA included one primer (Sh110: 5' TTCCTCCAACTACCATCTTATCTC) based on a newly identified S. haematobium repetitive sequence termed Sh110 (Figure 1A
), and a second primer (Sm-SL: 5'AACCGTCACGGTTTTACTCTTGTG) based on the highly abundant S. mansoni splice leader sequence.19 The degree of similarity of the S. mansoni splice leader sequence to that of S. haematobium and of other schistosomes is likely to be high, given that the same splice leader primer sequence is found (with complete identity) in protein mRNA sequences of S. japonicum, as shown by a Blast search in the GenBank.
|
For detecting S. haematobiuminfected snails by PCR, preliminary experiments were carried out for establishing DNA extraction conditions and PCR conditions by testing snail bodies spiked with schistosomal DNA. Further examinations were carried out with infected and uninfected field-collected snails. Conditions for snail PCR have been described elsewhere.15
Nucleotide sequencing. Plasmid Isolation Kit (Quiagen, Chatsworth, CA) was used according to the instructions of the manufacturer for obtaining DNA from recombinant plasmids selected for sequence analysis. Nucleotide sequence analysis was carried out using Dye Terminator Cycle Sequencing kit (Perkin Elmer, Wallington, UK) according to the instructions of the manufacturer. An ABI PRISM 377 DNA Sequencer and ABI Sequencing Analysis software (Perkin Elmer, Foster City, CA) were used. The thermal profile was 10 seconds at 96°C, 5 seconds at 50°C, and 4 minutes at 60°C for 25 cycles. Consensus sequence was analyzed by employing the Wisconsin Package (Genetic Computer Group, Madison, WI).
| RESULTS |
|
|
|---|
We next examined an alternative possibility to accomplish this goal. This involved attempts at inter-repeat amplification using mixed primer pairson one end, a primer designed from newly identified S. haematobium repeat sequences, and on the other end, a primer based on known Schistosoma splice-leader sequence (taken from S. mansoni sequence19 and common to S. japonicum). A total of 52 such mixed primer pairs were used in this part of the search (Table 1
|
Structure, abundance, and arrangement of the Sh110 repeated sequence.
This 120-bp sequence, derived from a Sau3AI library of S. haematobium (Figure 1A
), is flanked by a GAT-rich region with GAT repeated 50 times (results not shown). Although our study detected the presence of this repeated sequence in S. haematobium, its relation to any particular repeated gene or non-coding sequence of S. haematobium is yet unknown.
The abundance of the Sh110 sequence has not been directly determined but can be inferred, with some approximation, from the abundance of the amplified sequence (see below).
The arrangement of the Sh110 repeated sequence was determined by Southern blot analysis using a Sh110 clone as probe. Several bands of different sizes were obtained (results not shown), as was also found with the Sm-Sl/Sh110 PCR product (see below), but there was no ladder banding pattern typical of tandem repeated sequences.14,20,21 These results suggested that the Sm110 repeat sequence is dispersed in the genome,
Structure, abundance, and arrangement of the Sh110/Sm-Sl PCR product.
The DNA amplification by PCR using the Sh110 and Sm-S1 primers yielded a 525-bp product (GenBank accession no. DQ831696). The position of the 5' end was inferred from the known position of the S. mansoni splice leader sequence.19 The PCR products sequence and the corresponding primers are presented in Figure 2
. A Blast search in the GenBank identified a high degree of sequence homology between parts of this PCR product (93- to 122-bp-long segments) and a number of schistosomal sequences, including S. haematobium acetylcholinesterase gene (accession no. AY167025). However, the amplified sequence, as presented in its entirety (Figure 2
), is not represented in the GenBank.
|
The arrangement in the S. haematobium genome of the DNA segment amplified by Sm-Sl/Sh110 PCR seems to be dispersed given that several bands of different sizes were exhibited (Figure 3
). Bands with corresponding sizes of about 260 bp (Figure 3
, lane 1-RsaI cut DNA) and both 260 and 520 bp (Figure 3
, lane 2-AluI cut DNA) were exhibited, the latter identical to the size of the amplification product. Given that discrete bands were obtained by Southern hybridization with the corresponding probe (Figure 3
), it is unlikely that hybridization occurred with small segments having only partial sequence homology (e.g., parts of the splice leader sequence) but rather with the full sequence of the amplification product or with large parts of it.
|
|
|
10 ng S. haematobium DNA is examined (results not shown). Differentiation between S. haematobium and S. intercalatum, the other species that exhibits a second amplification band (of ~450 bp in this case), remains possible by the different size of the second band, as well as by the higher amount of DNA required for obtaining amplification products with S. intercalatum DNA.
Detection of S. haematobiuminfected snails by PCR.
Bulinus nasutus snails, known to be either infected or uninfected with schistosomes based on DraI-PCR testing, were subsequently examined by Sm-Sl/Sh110 PCR. Infected and uninfected snails were clearly distinguished (Figure 6
), and sensitivity for S. haematobium DNA detection in snail extracts was further established by addition of DNA to extracts of uninfected snails (results not shown are similar to Figure 4
).
|
| DISCUSSION |
|
|
|---|
Of the S. haematobiumrelated schistosome species examined in this study, S. bovis is the most widespread and prevalent,7,8 and thus has the widest potential geographical overlap with S. haematobium. The other species examined are less widely distributed. These are the animal schistosomes, S. mattheei, found in southern Africa,7 S. margrebowiei, found in a relatively small area in west and southern Central Africa,7 and S. curassoni, found primarily in western Africa.7,23 S. intercalatum, belonging to the same group and causing sporadic schistosomiasis in humans, is found in foci in central Africa within Equatorial Guinea, Sao Tome, Nigeria, and Mali.9 S. leiperi, another animal schistosome, the distribution of which overlaps that of S. margrebowiei in southern Central Africa,7 was not examined in this study.
This report describes the differential identification of S. haematobium from the related schistosomes S. bovis, S. mattheei, S. curassoni, and S. intercalatum by simple PCR. In contrast, the much less common S. margrebowiei was not successfully differentiated from S. haematobium, as it yielded an amplification product of the same size (Figure 5
). In practical terms, S. haematobiuminfected snails can now be clearly differentiated from snails carrying the most prevalent, related animal schistosomes in Africa (i.e., S. bovis and S. mattheei),7 as well as from S. curassoni in areas where it is found alongside S. haematobium. These results will allow extension of large-scale PCR monitoring approaches for snails infected with S. haematobium,15 which had been previously limited to areas where cross-reacting (DraI containing) animal schistosome species were absent or very rare.
In addition to differentiation between S. haematobium and its related species, specific identification of S. interalatum (Figure 5
) could facilitate better study of the distribution of this species and may also help to better define the effects of competition between S. intercalatum and S. haematobium in sympatric endemic areas.9 The fact that S. curassoni can be differentiated from S. haematobium, as well as from the other species tested, may help to resolve doubts about the identity of S. curassoni as a distinct species.7
Further validation of the assay is needed for field studies because only a few field-collected snails were examined in this study. Such validation should include a whole range of infected and uninfected snails with different signal intensities (as detected by DraI PCR)15 to assess the range of sensitivity among field-collected snails. Although PCR has been shown to be practical for large-scale monitoring of S. haematobium transmission in affected communities,15 a more inexpensive and robust detection method will greatly facilitate implementation of molecular monitoring of transmission potential in large-scale control projects.
Received September 10, 2006. Accepted for publication October 27, 2006.
Acknowledgments: The authors thank Dr. David A. Johnston, from the Biomedical Parasitology Division, Department of Zoology, Natural History Museum, London, UK, for providing us with specimens of the schistosome species examined in the study.
Financial support: This research was supported by the National Institute of Allergy and Infectious Diseases and the Fogarty International Center of the U.S. National Institute of Health under Grants AI45473 (NIAID) and TW/ES01543 (Fogarty International Center).
* Address correspondence to Ibrahim Abbasi, Department of Parasitology, Kuvin Center for the Study of Infectious and Tropical Diseases, Hebrew University, Hadassah Medical School, P.O. Box 12272, Jerusalem 91120, Israel. E-mail: ibrahim{at}md.huji.ac.il ![]()
Authors addresses: Ibrahim Abbasi and Joseph Hamburger, Department of Parasitology, Kuvin Center for the Study of Infectious and Tropical Diseases, Hebrew University, Hadassah Medical School, PO Box 12272, Jerusalem 91120, Israel, Telephone: 972-2-6758087, Fax: 972-2-6757425, E-mail: ibrahim{at}md.huji.ac.il. Charles H. King, Center for Global Health and Diseases, Wolstein 4126, CWRU School of Medicine, 10900 Euclid Avenue, Cleveland, OH, 44106-7286, Telephone: 216-368-4818, Fax: 216-368-4825, E-mail: chk{at}po.cwru.edu. Robert F. Sturrock, 92 Brennand Road, Dongara WA6525, Australia, E-mail: sturrock{at}iprimus.com.au. Curtis Kariuki and Eric Muchiri, Division of Vector Borne Diseases, Ministry of Health, PO 20750, Nairobi, Kenya, Telephone: 254-20-725833, Fax: 254-20-720030, E-mail: schisto{at}wananchi.com.
The structure and other characteristics of the various repeated sequences found in the course of our search are beyond the scope of the present report, which centers on differential identification of S. haematobium, and will be detailed in a future publication. Those 27 clones that provided primers for inter-repeat amplification with the Sm-Sl primer were deposited in the GenBank (accession nos. DQ831697DQ831706). ![]()
| REFERENCES |
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |